Los Angeles Capital Management LLC Cuts Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Los Angeles Capital Management LLC cut its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 2.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,414 shares of the company’s stock after selling 297 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Addus HomeCare were worth $1,431,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of ADUS. Creative Planning boosted its stake in Addus HomeCare by 5.8% during the third quarter. Creative Planning now owns 4,910 shares of the company’s stock worth $653,000 after buying an additional 267 shares during the period. Louisiana State Employees Retirement System boosted its stake in Addus HomeCare by 7.4% during the third quarter. Louisiana State Employees Retirement System now owns 8,700 shares of the company’s stock worth $1,157,000 after buying an additional 600 shares during the period. State of Alaska Department of Revenue boosted its stake in Addus HomeCare by 7.6% during the third quarter. State of Alaska Department of Revenue now owns 10,215 shares of the company’s stock worth $1,358,000 after buying an additional 721 shares during the period. J.W. Cole Advisors Inc. purchased a new position in Addus HomeCare during the third quarter worth $251,000. Finally, Integrated Advisors Network LLC purchased a new position in Addus HomeCare during the third quarter worth $523,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Price Performance

ADUS stock opened at $95.77 on Friday. The business has a 50-day moving average price of $122.60 and a 200 day moving average price of $126.08. The company has a market capitalization of $1.74 billion, a P/E ratio of 21.92, a PEG ratio of 1.41 and a beta of 1.00. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Macquarie reaffirmed an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday. Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Stephens decreased their target price on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating for the company in a research report on Wednesday. JMP Securities began coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. Finally, StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.